title: Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling.
authors.forename: Harel
authors.initials: H
authors.lastname: Dahari
authors.forename: Scott J
authors.initials: SJ
authors.lastname: Cotler
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Layden
authors.forename: Alan S
authors.initials: AS
authors.lastname: Perelson
mesh_terms: D005260:Female; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000235:genetics* / Q000821:virology*; D006801:Humans; D007378:Interleukins / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide
chemical_list: D007378:Interleukins